Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination therapy using an IL-20 antagonist and an immune checkpoint inhibitor

Combination therapy using an IL-20 antagonist and an immune checkpoint inhibitor

US Patent 11661450 · Granted May 30, 2023

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treating tissue fibrosis with interleukin 242025
Use of IL-20 antagonists for treating eye diseases2022
Use of IL-20 antagonists for treating pancreatic cancer2018
Antibodies which specifically bind to canine vascular endothelial growth factor 2017
Method of inhibiting adipogenesis with an IL-20 antibody2017
Humanized anti-IL-20 antibody and uses thereof2017
Use of IL-20 antagonists for alleviating spinal cord injury2016
Treatment of inflammatory pain using IL-20 antagonists2016
Use of IL-20 antagonists for treating liver diseases2016
Treatment of osteoarthritis using IL-20 antagonists2015
Humanized anti-IL-20 antibody and uses thereof2015
Methods for treating osteoporosis with anti-IL-20 receptor antibodies2015